Trial intelligence / Profile preview

HS-10384 for Vasomotor Symptoms in Menopausal Women (Phase II, Randomized, Double-Blind, Placebo-Controlled)

ChiCTR2400083770Phase 2Not yet recruiting

Sponsor
Peking Union Medical College Hospital
Start
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of HS-10384 in vasomotor symptoms (3 arms), sponsored by Peking Union Medical College Hospital. Planned start Apr 2024; status: not yet recruiting.

02

Drugs

HS-10384
03

Conditions

vasomotor symptoms

Beyond the preview

Go deeper on ChiCTR2400083770.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400083770.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call